Caredx announces ceo transition

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – announced today that dr. reginald seeto will be stepping down from his position as chief executive officer and president and resigning as a director of the board effective november 1, 2023, and will transition to the role of senior advisor to the.
CDNA Ratings Summary
CDNA Quant Ranking